Computer-aided system of evaluation for population-based all-in-one service screening (CASE-PASS): From study design to outcome analysis with bias adjustment

Annals of Epidemiology

Volumn 20, Issue 10, 2010, Pages 786-796

  Chen, Li Sheng ^a,c   Yen, Amy Ming Fang ^a,c   Duffy, Stephen W ^d   Tabar, Laszlo ^e   Lin, Wen Chou ^b   Chen, Hsiu Hsi ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^e FALUN HOSPITAL   (Sweden)

Author keywords

Computer aided System; Lead Time; Population based Screening; Quasi Experimental Design; Self Selection Bias

Indexed keywords

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; COLORECTAL CANCER; COMPUTER AIDED SYSTEM OF EVALUATION FOR POPULATION BASED ALL IN ONE SERVICE SCREENING; COMPUTER PROGRAM; CONCEPTUAL FRAMEWORK; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; UTERINE CERVIX CANCER; COMPUTER ANALYSIS; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MASS SCREENING; PROCEDURES; PUBLIC RELATIONS; RISK; STATISTICAL BIAS; SURVIVAL; SWEDEN; TRENDS;

BIAS (EPIDEMIOLOGY); COMPUTING METHODOLOGIES; FEMALE; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MASS SCREENING; RISK; SURVIVAL ANALYSIS; SWEDEN;

EID: 77956260374     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2010.06.003     Document Type: Article

References (21)

1. Tábar L., Vitak B., Chen H.H., Duffy S.W., Yen M.F., Chiang C.F., et al. The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000, 38:625-651.
2. Nyström L., Rutqvist L.E., Wall S., Frisell J., Nordenskjöld B., Rutqvist L.E. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993, 34:1973-1978.
3. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993, 328:1365-1371.
4. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., Moss S.M., Amar S.S., Balfour T.W., et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
5. Kronborg O., Fenger C., Olsen J., Jørgensen O.D., Søndergaard O. Randomized study as of screening for colorectal cancer with faecal occult blood test. Lancet 1996, 348:1467-1471.
6. Chang C.M., Kuo H.S., Chang S.H., Chang H.J., Liou D.M., Laszlo T., et al. Computer-aided disease prediction system: development of application software with SAS component language. J Eval Clin Pract 2005, 11:139-159.
7. Tábar L., Fagerberg C.J., Gad A., Baldetorp L., Holmberg L.H., Gröntoft O., et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985, 325:829-832.
8. Duffy S.W., Tabar L., Chen H.H., Holmqvist M., Yen M.F., Abdsalah S., et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: a collaborative evaluation. Cancer 2002, 95:458-469.
9. Bjurstam N., Björneld L., Warwick J., Sala E., Duffy S.W., Nyström L., et al. The Gothenburg Breast Screening Trial. Cancer 2003, 15(97):2387-2396.
10. Andersson I., Aspegren K., Janzon L., Landberg T., Lindholm K., Linell F., et al. Mammographic screening and mortality from breast cancer: The Malmö Mammographic Screening Trial. Br Med J 1988, 297:943-948.
11. Frisell J., Eklund G., Hellström L., Lidbrink E., Rutqvist L.E., Somell A. Randomized study of mammography screening-preliminary report on mortality in the Stockholm Trial. Breast Cancer Res Treat 1991, 18:49-56.
12. Labrie F., Candas B., Cusan L., Gomez J.L., Bélanger A., Brousseau G., et al. Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec Prospective Randomized Controlled Trial. Prostate 2004, 59:311-318.
13. Hakama M., Räsänen-Vintanen V. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol 1976, 103:512-517.
14. Duffy S.W., Cuzick J., Tabar L., Vitak B., Chen T.H.H., Yen M.F., et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Stat 2002, 51:235-243.
15. Cuzick J., Edwards R., Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997, 16:1017-1029.
16. Chang C.M., Lin W.C., Kuo H.S., Yen M.F., Chen T.H. Estimation and prediction system for multi-state disease process: application to analysis of organized screening regime. J Eval Clin Pract 2007, 13:867-881.
17. Cook T.D., Campbell D.T. Quasi-experiments: nonequivalent control group designs. Quasi-experimentation: design & analysis issues for field settings 1979, 98-103. Houghton Mifflin Co, Boston.
18. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006, 15:45-51. The Swedish Organized Service Screening Evaluation Group.
19. Reduction in breast cancer mortality from organized service screening with mammography: 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev 2006, 15:52-56. The Swedish Organized Service Screening Evaluation Group.
20. Habbema J.D., van Oortmarssen G.J., Lubbe J.T., van der Maas P.J. The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed 1985, 20:79-93.
21. Duffy S.W. Cancer screening in Asia. J Med Screen 2006, 13(Suppl 1):S1.